Alternative treatments in transmissible venereal tumor in canines

Authors

  • Isabella Geraldine Quiroga Sánchez Universidad de la Salle
  • Alba Cristina Espinosa Nuñez Universidad de la Amazonia
  • Frank Harry Suárez Sánchez Universidad de la Salle

DOI:

https://doi.org/10.21615/cesmvz.15.3.2

Keywords:

autohemotherapy, immunotherapy, chemotherapy, TVT

Abstract

Transmissible Venereal Tumor (TVT) is a common canine neoplasia; it is
mainly located in the genital mucosa. This pathology is highly contagious
and can be transmitted by direct contact cell transplantation from a diseased
to a non-diseased mucosa. It is primarily diagnosed by cytology and its
treatment is chemotherapy being the vincristine sulfate the medicine of
choice. The Vincristine has a high rate of effectiveness and low recidivism;
however, this alternative has important side effects. The treatment with
Vincristine could cause primarily digestive upset, hematological, and nervous
diseases. The objective of this work is to determine the efficacy and
performance of alternative therapies for the treatment of TVT, firstly, with
an autohemoterapy protocol, and using an immunotherapy treatment with
yatrenic acid and casein, which acts in the animal’s immune system and
causes the same organism to eradicate the tumor.

Downloads

Download data is not yet available.

References

Alcaldía de Florencia. Alcaldía de Florencia. [14 de octubre de 2013]. Disponible en: http://www.florencia-caqueta.gov.co.

Amber EL, Henderson RA, Adeyanju JB, Gyang EO. Single-drug chemotherapy of canine transmisible veneral tumor with cyclosphosphamine, metrotrexate, or vincristine. Journal of Veterinary Internal Medicine. 1990; 4 (3): 144-147.

Aprea AN, Allende MG, Idiard R. Tumor Venéreo Transmisible Intrauterino: descripción de un caso. Veterinaria Argentina XI. 1994; 103: 192-194.

Batamuzi EK, Kristensen F. Urinary tract infection: the role of canine transmissible venereal tumor. Journal of Small Animal Practice. 1996; 37 (6): 276-279.

Patiño-Quiroz B, Baldrich-Romero N, Fuentes-Villamil C, Espinosa-Nuñez A. El Tumor Venéreo transmisible dentro de la clasificación de neoplasias en caninos. Revista Electronica de Veterinaria REDVET. 2020 [junio de 2020]; 21 (2): 72-81. Disponible en: https://www.veterinaria.org/index.php/REDVET/article/view/48

Calero Herrera I, Reginal Eustace JC, Rodríguez F. Comprobación de la efectividad de dos esquemas terapéuticos en el tratamiento del Tumor de Sticker en perros. Revista Electrónica de Veterinaria REDVET. 2006 [octubre de 2006]; 7 (7): 1-7. Disponible en: https://www.redalyc.org/pdf/636/63617167017.pdf

Calvet CA, Leifer CE, Mcewen EG. Vincristine for the treatment of transmissible venereal tumor in the dog. Journal of American Veterinary Medical Association.1982; 181 (2): 163-164.

Cockrill JN, Beasly JN. Ultra Structural Characteristics of canine transmissibles veneral tumor at various stages of growht and regression. American Journal of veterinary research. 1975; 36 (5): 677-681.

Cohen D. In vitro cell mediated cytotoxicity and antibody dependent cellular cytotoxicity to the transmissible venereal tumor of the dog. Journal of the National Cancer Institute. 1980; 64 (2): 317-321.

Cohen D. The canine transmissible venereal tumor; A unique resul of tumor progression. Advance Cancer Research. 1985; 43: 75-112.

Cuddon PA. Acquired canine peripheral neuropathies. Veterinary Specialists of Northern Colorado. 2002; 32 (1): 207-249.

Daleck CR, Francheschini P, Padilha JG, Alessi AC, Garcia JM, Martins M. I, Costa Neto JM. Análise histológica de testículos e semen de caes submetidos a administracao de sulfato de vincristina. Brazilian Journal of Veterinary Research ans Animal Science. 1995; 32 (1): 51-56.

De la Sota P, D'amico G, Adagio L, Noia M, Gobello C. Tumor Venéreo Transmisible en el Perro. Ciencia Veterinaria. 2004; 6 (1):1-10.

Espinosa A, Muñoz L, Nastar N. Inmunoterapia como tratamiento alternativo para el tumor venéreo transmisible: reporte de caso. Fagropec. 2014; 6 (1): 46-55.

Flores PE, Diez YX, Diaz RA, Urcelay VS, Cattaneo UG. Comparison of the neoplasms recorded in two periods (1981-1985 and 1986-1988) at the surgery section of the faculty of Veterinary Medicine. Avances en Ciencias Veterinarias University of chile. 1993; 8 (1): 61-65.

González Cruz G, Sánchez Buitrado CA, Vélez Hernández ME, De Buen N. Neoplasias en aparato reproductor en perras: estudio retrospectivo de 6 años. Vet. México. 1997; 28 (1): 31-34.

Hill DL, Yang TJ, Wachtel A. Canine transmissible venereal sarcoma: tumor cell and infiltrating leukocyte ultra striucture at different growth stages. Veterinary Pathology.1984; 21 (1): 39-45.

Hoque M, Kumar N, Singh GR, Charan K, Pawde AM. (1993). Efficacy of vincristine in management of canine transmissible venereal tumour. Indian Journal of Veterinary Medicine. 1993; 13 (2): 69.

Hoque M, Singh GR, Pawde A. Electrosurgey versus scalpel surgery in canine transmissible venereal tumor. indian journal of veterinary research. 1995; 48 (9): 686-688.

Laredo M. Natural News. 2008 [20 de octubre de 2013]; Disponible en: http://www.naturalnews.com/023107_iodine_body_thyroid.html#

Leite FD. (2008). Auto-hemoterapia, Intervenção do Estado e Bioética. Rev. Assoc. Med. Bras. 2008; 54 (2): 183-188

MacEwen EG. (1996). Transmissible Veneral Tumor en Withron. Small Animal Clinical Oncology. 5 ed. Saunders. 1996. Pág. 533-537.

Mettenleiter M. (1936). Autohemotransfusion in Preventing Postoperative Lung. The American Journal of Surgey. 1936; 32 (2): 321-326.

Morrison WB. Cancer in dogs and cats. En W. e. Wilkings, Medical and Surgical Management. Teton NewMedia. 2002; 359.

Moulton, JE. Tumors in domestic animals. Vol 1. 2nd ed. Berkely: University of California press; 1978.

Moura L. Auto-Hemoterapia Contribución para la salud. (A. Martinez, L. F. Sarmento, Entrevistadores). 2004

Paula LF, Ferrerira H, Peres JA, Teixeira RB, Franco AP. Metastase de Tumor Venéreo Transmissivel em figado e baco. Congresso Brasileiro de clínicos veterinários de peqeños animais Anais XIX. 1997. Pág. 30.

Ramírez Pérez YE, Reyes Ávila IR, Rodríguez Valera Y, Cuesta Guillén AF, Pérez Castro LE. Tumor venéreo transmisible en un perro mestizo y su respuesta a la quimioterapia citostática. Redvet - Revista Electrónica de Veterinaria. 2011; 12 (6): 1-5.

Rogers KS. Transmissible venereal tumor. En Compendium on Continuing Education-Practical Veterinary. USA. 1997. p.1036-1045.

Sali G. Recomendaciones de utilización para la terapia bioestimulante con Yatren-Caseina® en la medicina veterinaria. Clínica Veterinaria S. Francesco, S. Nicolò en Trebbia. 2010: 1-7.

Santin AP, Brito LA. Estudio da Papilomatose Cutánea em Bovinos Leiteiros; Comparacao de Direferentes Tratamentos. Ciência Animal Brasileira. 2004; 5 (1): 39-45.

Shakman S. Autohemoterapia: a picada mágica? 2007. Disponible en: http://paginas.terra.com.br/saude/Autohemoterapia/AUTOHEMOTHERAPY_THE_MAGIC_SHOT_Stuart_Shakman.pdf

Singh J, Rana JS, Sood N, Pangawkar GR, Gupta PP. Clinico-pathological studies on the effect of different anti-neoplastic chemotherapy regimens on transmissible venereal tumours in dogs. Veterinary Research Communications. 1996; 20 (1): 71-81.

Sousa J, Saito V, Nardi AB, Rodaski S, Guerios SD, Bacila M. Características e Incidencia do tumor venereo transmissivel (TVT) em caes e ediciencia da quimioterapia e outros tratamentos. Archives of Veterinary Science. 2000; 5 (1): 41-48.

Stephenson WT, Poirier SM, Rubin L, Einhorn LH. (1995). Evaluation of reproductive capacity in germ cell tumor patients following treatment with cisplatin, etoposide, and bleomycin. Journal Clinical Oncology. 1995;13 (9): 2278-2280.

Tasqueti UI, Martins M, Boselli CC, Bracarense A. Um caso atipico de TVT com deslocamento cranial de vagina. XX Congreso Brasileiro de Clinicos Veternarios de Pequeños Animais. 1999; 38: 38.

Tinucci-Costa M. Tumor venereo transmissivel: estudios inmunohistoquímicos e de transplantacoes xenogenica e alogenicas. Tesis de Doctorado. Facultad de Medicina da Universidade de Sao Paulo, Ribeirao Preto. 1999. Pág. 144.

Tinucci-Costa M, Souza L, Faria JR, Granja NM, Figuereido F, Soares FA. A puncao de medula é importante no pronóstico do tumor venéreo transmissivel canino. Journal Brazilian of Pathology Supplement. 1997; 33: 143.

Tricca G. Vet-Uy agro y veterinaria. 2013 [28 de agosto de 2020]. Disponible en: www.vet-uy.com/articulos/caninos/050/0025/can0025.htm

Vermooten MJ. (1987). Canine transmissible venereal tumor (TVT). Journal of the South African Veterinary Association. 1987; 58 (3): 147-150.

Veronesi R. Imunoterapia: o impacto médico do século. Revista Medicina de Hoje. 1976; Volume 2:194.

White RA. Manual of Small Animal Oncology. London: British Small Animal Veterinary Association. 1991.

Yang TJ, Roberts RS, Jones JB. (1976). Quantitative Study of limphoreticular infiltration into canine transmissible venereal sarcome. Virchows Archive B: Cell Pathology. 1976; 20 (1): 197-204.

Yang TJ, Palker TJ, Harding MW. (1991). Tumor size, leukocyte adherence inhibition and serum levels of tumor antigen in dogs with the canine transmissible venereal sarcomo. cancer inmunology, Inmunotherapy. 1991; 33 (4): 255-256.

Published

2020-12-19

How to Cite

Quiroga Sánchez, I. G., Espinosa Nuñez, A. C., & Suárez Sánchez, F. H. (2020). Alternative treatments in transmissible venereal tumor in canines. CES Medicina Veterinaria Y Zootecnia, 15(3), 25–40. https://doi.org/10.21615/cesmvz.15.3.2

Issue

Section

ARTÍCULO ORIGINAL DE INVESTIGACIÓN
Article metrics
Abstract views
Galley vies
PDF Views
HTML views
Other views

Some similar items: